[1] Tse E, Kwong YL. The diagnosis and management of NK/T-cell lymphomas [J]. J Hematol Oncol, 2017, 10(1):85. [2] Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type [J]. Clin Oncol (R Coll Radiol), 2008, 20(8):619-625. [3] Haverkos BM, Pan Z, Gru AA, et al. Extranodal NK/T cell lymphoma, nasal type (ENKTL-NT): An update on epidemiology, clinical presentation, and natural history in north American and European cases [J]. Curr Hematol Malig Rep, 2016, 11(6): 514-527. [4] Harabuchi Y, Takahara M, Kishibe K, et al. Extranodal natural killer/T-cell lymphoma, nasal type: Basic science and clinical progress [J]. Front Pediatr, 2019, 7:141. [5] 王丹丹,杨宏宇,王宇帆,等.伴面部肿胀结外鼻型NK/T细胞淋巴瘤1例报告及文献复习[J].中国口腔颌面外科杂志,2017,15(4):382-384. [6] 沙秀娟,江姗,杨冬叶,等.1例鼻腔NK/T细胞淋巴瘤伴发腭部缺损患者行腭护板修复的个案护理[J].中国口腔医学继续教育杂志,2022,25(6):397-401. [7] Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]. Blood, 2016, 127(20): 2375-2390. [8] 穆新月,刘树泰,孙继军,等.以口腔溃疡为首发症状的鼻型-结外自然杀伤/T细胞淋巴瘤1例[J].华西口腔医学杂志,2022,40(3):355-359. [9] Nagato T, Takahara M, Harabuchi Y. Ulcerated lesions of the midline gingiva and soft palate [J]. Am J Med Sci, 2020, 360(1): 77. [10] Niwa H, Mukai K, Kimura I, et al. A case of extranodal NK/T-cell lymphoma, nasal type, diagnosed by scraping cytology of the maxillary gingiva [J]. Diagn Cytopathol, 2024, 52(2):E39-E43. [11] Al-Hakeem DA, Fedele S, Carlos R, et al. Extranodal NK/T-cell lymphoma, nasal type [J]. Oral Oncology, 2007, 43(1): 4-14. [12] Horwitz SM, Ansell SM, Ai WZ, et al. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018 [J]. J Natl Compr Canc Netw, 2018, 16(2):123-135. [13] Sánchez-Romero C, Bologna-Molina R, Paes de Almeida O, et al. Extranodal NK/T cell lymphoma, nasal type: An updated overview [J]. Crit Rev Oncol Hematol, 2021, 159:103237. [14] Meng W, Zhou Y, Zhang H, et al. Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review[J]. Pathol Oncol Res, 2010, 16(1):133-137. [15] Tian C, Wang Y, Zhu L, et al. Primary bone natural killer/T cell lymphoma, nasal type without EBV infection: a case report [J]. Int J Clin Exp Pathol, 2015, 8(11): 14836-14839. [16] Hue SS, Oon ML, Wang S, et al. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach [J]. Pathology, 2020, 52(1): 111-27. [17] Syrykh C, Péricart S, Lamaison C, et al. Epstein-barr virus-associated T- and NK-cell lymphoproliferative diseases: A review of clinical and pathological features [J]. Cancers (Basel), 2021, 13(13):3315. [18] He X, Gao Y, Li Z, et al. Review on natural killer/T-cell lymphoma [J]. Hematol Oncol, 2023, 41(2): 221-229. [19] Tse E, Zhao WL, Xiong J, et al. How we treat NK/T-cell lymphomas[J]. J Hematol Oncol, 2022, 15(1): 74. [20] Wang H, Fu BB, Gale RP, et al. NK-/T-cell lymphomas [J]. Leukemia, 2021, 35(9): 2460-2468. |